Latest News
IMA Group Acquires Diagnostics Research Group to Expand Clinical Research Offerings
Wednesday 13 October 2021

New York-based network of clinical research sites IMA Group (IMA) has acquired Texas-based Diagnostics Research Group to broaden IMA's clinical research offerings, the company said.

Terms of the transaction were not disclosed.

The acquisition marks the company's fourth this year and extends IMA's access to diverse patient populations and its expansion into the southwestern United States.

It also adds to IMA's growing Clinical Research Division and its more than 90 brick-and-mortar medical offices. The move aligns with IMA's mission to reach people everywhere, as it partners with its sponsors to develop safe and effective new treatments.

Diagnostics Research Group will continue to operate under its current name, with key leadership, investigators and staff remaining in place.

IMA Clinical Research, a division of The IMA Group, is a physician-founded network of integrated clinical research sites specialising in Phase II-IV clinical trials in multiple therapeutic areas.

Diagnostics Research Group is a clinical research site with expertise across a diverse array of medical specialties, including vaccine and medical device development, internal medicine, allergies, and pulmonary and fatty liver diseases.
Date Published: 13/10/2021